All abstracts, regardless of whether they are submitted for oral or poster presentation will be reviewed to appraise the quality of the work presented. The Scientific Committee will evaluate all abstracts submitted for presentation. The authors will be notified regarding acceptance of their abstracts and the type of presentation by June 15, 2023.
Submission Guidelines and General Policies
Before accessing the submission form, please make sure that you have prepared your abstract according to the following guidelines:
Language: All abstracts should be submitted and presented in English, which is the official language of the Meeting, using accurate grammar and spelling suitable for publication. If in doubt, please arrange for the review of your abstract by a native English speaker or by a university scientific publications office (or other similar facility) prior to submission, as it will be reproduced exactly as submitted. No proofreading will be done.
Corresponding Author: The abstract submission form should be completed by the Corresponding Author, who will be responsible for all future communications regarding the submitted abstract.
Account: Each submitter (Corresponding Author) is required to create a user account indicating an account email address and a password. The email and password indicated will be used for all online forms of the Meeting (i.e. Registration Form).
Abstract Title:- Abstract title should be brief and reflect the content of the abstract
- The abstract title should be typed in lower-case letters, except for abbreviations and study names. Please be careful that your title might be truncated if you copy and paste it into the field.
- Do not refer to study results or conclusions in the title of the abstract. The title should objectively describe the study.
Presentation type: Authors are invited to express their preference for oral or poster presentation; the final assignment will be made by the Scientific Committee.
Topic: Authors are invited to select the topic that better fits the scope of their abstract among the meeting topics; the final assignment will be made by the Scientific Committee.
Authors:- Names of authors should be written in upper/ lower cases in the following way: {Full name with first letter in upper case (e.g. John)} {Surname (Family Name) with first letter in upper case (e.g. Smith)}
- Please enter the first name in full, followed by the surname (Family Name), for each author, without abbreviations (e.g. John Smith, and NOT J. Smith). The names, e-mail addresses and full affiliations of all authors should be entered.
- In each abstract can have a maximum of 25 authors
Affiliations: The Affiliation should be written in upper/ lower cases and should include: Department, Institution/Hospital, City, State (if relevant), Country
Text Body:- The text (excluding title, authors, and affiliations) should not exceed 350 words.
- Organize the abstract according to four sections, identified by the following headers:
- Background
- Methods
- Results
- Conclusions
- Do not include illustrations with the abstract.
- Place abbreviations in parentheses immediately after the first mention of a term or phrase; the abbreviation can then be used throughout the abstract.
- Table(s), Figures and photographs may be included.
- Describe the objectives and results of the research in the abstract so that the Abstract Evaluation Committee can evaluate the quality, originality, and completeness of the abstract. Abstracts will be judged solely on the basis of the data in the submitted abstract.
Replacing or correcting an abstract submission: Do not resubmit an abstract through the online abstract submission platform. Do not submit the same abstract both through website and regular mail. Any corrections should be made by e-mail to the ACTC Meeting Secretariat.
Registration fees should accompany all abstract submissions. Presenters are expected to attend the ACTC Meeting and are required to pay the registration fee and all expenses involved.
The presentation of the abstract and its publication in the Final Program and the Abstract Book is conditional upon payment of the registration fee by the presenting author. Please note that in case we do not receive the requested payment, the abstract, much to our regret, will not be included neither in the Abstract Book nor in the Scientific Program of the Meeting.
New Article Collection SPECIAL CONTENT
On the occasion of the 6th ACTC meeting, Molecular Oncology will initiate a new article collection on the general thematic area of 'Liquid Biopsies'!
After the 6th ACTC meeting, participants are welcome to submit their latest research in the field of Liquid Biopsy to Molecular Oncology. Manuscripts may be submitted in the format of a Research Article, Short Report or Method (for more details on article types, please check the journal's author guidelines) using THIS LINK.
Manuscripts will be editorially assessed on the basis of novelty and completeness and will be subject to a regular peer review process. Accepted articles will be published on a continuous basis and featured on the special ACTC/Liquid Biopsy article collection.
Molecular Oncologyis an open access journal that publishes studies from across the cancer research continuum. It is owned by the charitable organization FEBS, which reinvests the full journal income to support young researchers through courses and fellowships. Molecular Oncology publishes 200 – 300 articles per year (with Review articles representing less than 10% of the content), and has an Impact Factor of 7,449. The journal has format-free submission requirements, and median time to first decision is 37 days for peer-reviewed articles (in 2022). Publication fees may be covered through the Wiley agreements with your institute or funder.
